FdaApplication
ANDA 218312
Identifiers
- fda_app_no: ANDA218312
Properties
| Property | Value |
|---|---|
| applicant_name | BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD |
| application_type | ANDA |
| approval_date | 2024-12-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION;SUBCUTANEOUS |
1 product